
|Articles|February 15, 2004
In-office test found useful adjunct to cystoscopy
Las Vegas--An in-office bladder cancer test is significantly more sensitive than cytology at detecting the disease in high-risk patients, report community-based urologists from Anchorage, AK. The test also appears to be effective at determining risk of recurrence in patients with known disease, at least in the short term.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Dosing begins in trial of alpha radioligand therapy for mCRPC
2
Novel tool may help predict early PSA response to ARPIs in mHSPC
3
Fed Ghali, MD, highlights trial of consolidative local therapy following EV/P
4
RCMIGI trial supports feasibility of reduced margins in image-guided prostate radiotherapy
5




















